GoatVac C.D.-TThis page contains information on GoatVac C.D.-T for veterinary use.
The information provided typically includes the following:
- GoatVac C.D.-T Indications
- Warnings and cautions for GoatVac C.D.-T
- Direction and dosage information for GoatVac C.D.-T
GoatVac C.D.-TThis treatment applies to the following species:
Clostridium Perfringens Types C & D-Tetanus Toxoid
For use in healthy goats as an aid in the prevention of enterotoxemia caused by Clostridium Perfringens types B, C and D. Cl. Perfringens Type B is not a significant problem in North America.
For the long term protection against tetanus.
Contains thimerosal as a preservative.
Directions For Use
Do not vaccinate within 21 days before slaughter. Shake well before use. Use entire contents when first opened. Store at 2° to 7° C. Do not freeze.
PrecautionsAnaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent.
Dosage and AdministrationInject 2 ml. subcutaneously or intramuscularly. Repeat full dose in 3 to 4 weeks.
FOR VETERINARY USE ONLY
USDA Code No: 8304.00
Manufactured by: Colorado Serum Company, 4950 York St., Denver, CO. 80216
U.S. Vet License No. 188
Manufactured for: Durvet, Inc, 100 S.E. Magellan Drive, Blue Springs, MO. 64014
NAC No.: 10842540
P.O. BOX 279, 100 S.E. MAGELLAN DRIVE, BLUE SPRINGS, MO, 64014
|Every effort has been made to ensure the accuracy of the GoatVac C.D.-T information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-01-09